Analgesics in Australia
In 2023, Australians suffered from an extended influenza season, with months where people were prone to sickness. Analgesics had already seen strong growth in the last few years due to widespread illness as a result of COVID-19.However, strong growth is set to continue into 2023, due to the spread of other illnesses amongst Australians. Influenza vaccine rates in Australia have also declined compared with previous years, leaving people more vulnerable to getting the flu and spreading it to other...
Euromonitor International's Analgesics in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop
- Analgesics in Australia
- Euromonitor International
- September 2023
- List Of Contents And Tables
- ANALGESICS IN AUSTRALIA
- KEY DATA FINDINGS
- 2023 DEVELOPMENTS
- Analgesics sees strong growth amidst extended season for illness
- GSK Consumer Healthcare launches new range of natural acetaminophen, PanaNatra
- Pharmacies trends downwards, but remains the leading channel for analgesics
- PROSPECTS AND OPPORTUNITIES
- Steady growth expected for analgesics, but lack of new competing brands
- The TGA outlines plans to reduce the pack size of acetaminophen in Australia
- Ageing population will keep demand for analgesics high
- CATEGORY DATA
- Table 1 Sales of Analgesics by Category: Value 2018-2023
- Table 2 Sales of Analgesics by Category: % Value Growth 2018-2023
- Table 3 NBO Company Shares of Analgesics: % Value 2019-2023
- Table 4 LBN Brand Shares of Analgesics: % Value 2020-2023
- Table 5 Forecast Sales of Analgesics by Category: Value 2023-2028
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2023-2028
- CONSUMER HEALTH IN AUSTRALIA
- EXECUTIVE SUMMARY
- Consumer health in 2023: The big picture
- 2023 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
- Table 8 Life Expectancy at Birth 2018-2023
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2018-2023
- Table 10 Sales of Consumer Health by Category: % Value Growth 2018-2023
- Table 11 NBO Company Shares of Consumer Health: % Value 2019-2023
- Table 12 LBN Brand Shares of Consumer Health: % Value 2020-2023
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2018-2023
- Table 14 Distribution of Consumer Health by Format: % Value 2018-2023
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2023
- Table 16 Forecast Sales of Consumer Health by Category: Value 2023-2028
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook